Russian Federation
Vomiting is the symptom that can indicate a va-riety of diseases, from gastro-intestinal tract (gastri-tis, ulcer, foreign body, neoplasm, etc.) and other abdominal organs, which include diseases of the liver and gallbladder. In the study the dogs with toxic hepatitis were considered, one of leading symptoms of which was vomiting. The data of ani-mals were divided into 3 groups. Animals were di-vided into 3 groups. In the first group the standard scheme of treatment was applied. In the second group they additionally received the inhibitor of the proton pump (omeprazole) at a dosage of 2 mg/kg intravenously 2 times a day 3-5 days later in the form of capsules peros 2 mg/kg 2 times daily for up to 14 days. In the third group of dogs 2 times a day, further in the form of capsules of peros 4mgkg 2 of time a day till 14 days were appointed omeprazole (in the same dosages, as in the second group) and ranitidine (histamine blocker of H2-receptors) of 4 mg/kg intravenously. A comparative assessment of the application as an additional method of therapy in dogs with vomiting proton pump inhibitor and the blocker of histamine H2-receptors, established the cessation of vomiting during the first two days, which contributed to more rapid recovery of physio-logical functions of dogs such as appetite and mo-tor activity.
dog, vomiting, omeprazole, phamotidine
1. Zaigraeva I.S., Semenchenko S.V. Vliyanie smeny korma na rost i razvitie sluzhebnyh sobak // Vestnik KrasGAU. - 2015. - № 3 - S. 100-105.
2. Martynova N.A. K voprosu o profilaktike NPVP-associirovannoy gastroenteropatii // Medicina v Kuzbasse. - 2016. - T. 15. - № 4. - S. 21-23.
3. Minushkin O.N. , Maslovskiy L.V. , Loschinina Yu.N. [i dr.]. Omeprazol v lechenii bol'nyh gastroezofageal'noy reflyuksnoy bolezn'yu // Effektivnaya farmakoterapiya. - 2009. - № 9. - S. 20-27.
4. Predko V.A., Rutkevich A.S., Rutkevich E.Yu. [i dr.]. Primenenie blokatorov H2-gistaminovyh receptorov v intensivnoy terapii // Lechebnoe delo. - 2017. - № 3 (55). - S. 13-15.
5. Skosyrskih L.N., Stolbova O.A., Eydel'man M.S. [i dr.]. Gastroenterit sobak // Sovremennaya nauka - agropromyshlennomu proizvodstvu : sb. mat-lov Mezhdunar. nauch.-prakt. konf., posvyasch. 135-letiyu pervogo srednego uchebnogo zavedeniya Zaural'ya - Aleksandrovskogo real'nogo uchilischa i 55-letiyu GAU Severnogo Zaural'ya. - 2014. - S. 183-186.
6. Smolin S.G., Donskaya S.N. Soderzhanie obschego belka, glyukozy i trigliciridov v syvorotke krovi sluzhebnyh sobak pri primenenii raznoobraznyh racionov kormleniya // Vestnik KrasGAU. - 2017. - № 1. - S. 71-76.
7. Elwood C., Devauchelle P., Elliott J. [et al.]. Rvota u sobak: obzor // JSAP. - 2010. - T. 1. - № 1. - S. 5-21.
8. Paul L. Marino. The ICU Book. - 4th ed. - Philadelphia: PA, 2014.
9. Richter J.E., Kahrilas P.J., Johanson J. [et al.]. Effi cacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial // Am J. Gastroenterol. - 2001. - Vol. 96. - P. 656-665.
10. Vakil N., Fennerty M.B. Systematic review: Direct comparative trials of the effi cacy of proton pump inhibitors in the management of gastroesophageal refl ux disease and peptic ulcer disease // Aliment. Pharmacol. - Ther. 18; 559-568 (2003).
